Published in J Med Microbiol on November 01, 2002
Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol (2005) 2.83
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol (2003) 1.39
Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice. Antimicrob Agents Chemother (2003) 1.16
Infection with Scedosporium apiospermum and S. prolificans, Australia. Emerg Infect Dis (2007) 1.02
Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother (2003) 0.90
Adventitious sporulation in Fusarium keratitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.80
Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum. PLoS One (2017) 0.75
Positive blood cultures in a patient recovering from febrile neutropenia. JMM Case Rep (2016) 0.75
Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients. Mycopathologia (2017) 0.75
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother (1996) 5.27
Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect (2006) 2.67
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother (2001) 2.03
Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol (2009) 2.02
In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother (1997) 2.02
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
Emerging pathogens. Med Mycol (2000) 1.59
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents (2007) 1.57
Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect (2009) 1.55
Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother (1998) 1.54
Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B fgainst Fusarium. Antimicrob Agents Chemother (1997) 1.49
Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol (2011) 1.47
Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect (2009) 1.46
A new species of Syspastospora from tropical soils. Mycologia (2010) 1.45
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother (2001) 1.44
Comments on recent human infections caused by ascomycetes. Med Mycol (1998) 1.43
Psychomotor and intellectual development of children born with intrauterine growth retardation (IUGR). J Pediatr Endocrinol Metab (2004) 1.40
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol (2010) 1.35
Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek (1996) 1.29
Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol (2001) 1.29
Extended method for discrimination of Aeromonas spp. by 16S rDNA RFLP analysis. Int J Syst Evol Microbiol (2000) 1.28
Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol (1999) 1.24
Isolation and characterization of a new fungal species, Chrysosporium ophiodiicola, from a mycotic granuloma of a black rat snake (Elaphe obsoleta obsoleta). J Clin Microbiol (2008) 1.22
Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods. Antimicrob Agents Chemother (2000) 1.21
Pelvic oxyuriasis. Acta Obstet Gynecol Scand (1986) 1.19
Distribution of virulence genes in clinical and environmental isolates of Aeromonas spp. Antonie Van Leeuwenhoek (2003) 1.19
Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients. J Clin Microbiol (2001) 1.18
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab (2010) 1.16
Type III secretion system genes in clinical Aeromonas isolates. J Clin Microbiol (2004) 1.16
In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy (2001) 1.16
In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother (1999) 1.16
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother (2014) 1.13
In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi. Antimicrob Agents Chemother (2001) 1.13
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol (2010) 1.13
Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect (2008) 1.11
Bone fracture consolidates faster with low-power laser. Lasers Surg Med (1987) 1.10
In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother (1999) 1.08
Diversity of Bipolaris species in clinical samples in the United States and their antifungal susceptibility profiles. J Clin Microbiol (2012) 1.07
Phenotypic identification of Aeromonas genomospecies from clinical and environmental sources. Can J Microbiol (1998) 1.07
Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis (1991) 1.05
Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples. J Clin Microbiol (2011) 1.03
First record of the rare species Aeromonas culicicola from a drinking water supply. Appl Environ Microbiol (2005) 1.02
Clinically relevant Aeromonas species. Clin Infect Dis (2000) 1.02
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother (2012) 1.02
Prevalence of Salmonella serotypes in environmental waters and their relationships with indicator organisms. Antonie Van Leeuwenhoek (1999) 1.00
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1997) 0.98
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother (2013) 0.96
Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst (1999) 0.96
Characterisation of Aeromonas spp. isolated from frozen fish intended for human consumption in Mexico. Int J Food Microbiol (2003) 0.96
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes. J Clin Microbiol (2002) 0.95
Evaluation of two miniaturized systems, MicroScan W/A and BBL Crystal E/NF, for identification of clinical isolates of Aeromonas spp. J Clin Microbiol (2003) 0.95
A case of disseminated mycosis in a German shepherd dog due to Penicillium purpurogenum. Med Mycol (2006) 0.95
Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol (2010) 0.95
A DNA probe specific for Aeromonas colonies. Diagn Microbiol Infect Dis (2002) 0.95
Sporothrix brunneoviolacea and Sporothrix dimorphospora, two new members of the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia (2010) 0.94
Papillary neoplasms of the breast: clues in fine needle aspiration cytology. Cytopathology (2002) 0.93
Cutaneous phaeohyphomycosis caused by Caldosporium oxysporum and its treatment with potassium iodide. Med Mycol (2006) 0.92
Morphometric study of the neuromuscular synapses in the adult rat with special reference to the remodelling concept. Biol Cell (1987) 0.92
Effect of age on vanadium nephrotoxicity in rats. Toxicol Lett (1999) 0.91
Experimental infection with Scedosporium inflatum. J Med Vet Mycol (1992) 0.91
Morphological changes in strains of Aspergillus flavus Link ex Fries and Aspergillus parasiticus Speare related with aflatoxin production. Mycopathologia (1980) 0.90
Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses (2001) 0.90
Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp. J Antimicrob Chemother (2001) 0.89
New findings in black piedra infection. Br J Dermatol (1996) 0.88
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading. Mycopathologia (1999) 0.88
Microsphaeropsis olivacea as an etiological agent of human skin infection. Med Mycol (1999) 0.88
Minimal-change glomerulopathy and carcinoma. Report of two cases and review of the literature. Am J Nephrol (1993) 0.87
Virulence of Sporothrix luriei in a murine model of disseminated infection. Mycopathologia (2011) 0.87
[Two cases of scalp wound colonization and respiratory tract by mycelial fungi]. Rev Iberoam Micol (2000) 0.87
In vitro antifungal susceptibility of Alternaria spp. and Ulocladium spp. J Antimicrob Chemother (2000) 0.87
Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes. Med Mycol (2003) 0.86
A rare case of chromoblastomycosis in a renal transplant recipient caused by a non-sporulating species of Rhytidhysteron. Med Mycol (2008) 0.86
The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sci (2000) 0.85
Air-borne fungi in the air of Barcelona (Spain). IV. Various isolated genera. Mycopathologia (1980) 0.85
Branching pattern of the motor nerve endings in a skeletal muscle of the adult rat. J Anat (1990) 0.85
Angiolymphoid hyperplasia with eosinophilia of the tongue: report of a case and review of the literature. Hum Pathol (1991) 0.85
Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient. J Clin Microbiol (1995) 0.85
Controversial data on the association of Aeromonas with diarrhoea in a recent Hong Kong study. J Med Microbiol (2007) 0.84
Endogenous endophthalmitis by Fusarium solani: an animal experimental model. Med Mycol (1998) 0.84
Cerebral Pneumocystis carinii infection in AIDS. Lancet (1991) 0.84
Fungal endocarditis in premature infants: case report and review. Clin Infect Dis (1996) 0.83
Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum. Eur J Clin Microbiol Infect Dis (2002) 0.83
Evaluation of the oxolinic acid--esculin--azide medium for the isolation and enumeration of faecal streptococci in a routine monitoring programme for bathing waters. Can J Microbiol (1998) 0.83
Vessel hyalinization phenomenon in the laser treatment of tuberous hemangiomas and port wine stains. J Dermatol Sci (1995) 0.82
Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol (2003) 0.82
Relationship between presence of Salmonella and indicators of faecal pollution in aquatic habitats. FEMS Microbiol Lett (1998) 0.82
Subchronic oral toxicity of zinc in rats. Bull Environ Contam Toxicol (1988) 0.81
CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives. Hum Exp Toxicol (2008) 0.81
In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility. Chemotherapy (2003) 0.81
Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow. Cancer Epidemiol Biomarkers Prev (1999) 0.81
Use of restriction fragment length polymorphism of the PCR-amplified 16S rRNA gene for the identification of Aeromonas spp. J Clin Microbiol (2000) 0.81